Reduction in insulin sensitivity following administration of the clinically used low-dose pressor, norepinephrine

Diabetes/Metabolism Research and Reviews

Volumn 27, Issue 6, 2011, Pages 604-608

  Khoury, Nadia ^a   Mcgill, Janet B ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Critical care; Hyperglycaemia; Hyperinsulinaemic euglycaemic clamp; Insulin resistance; Vasopressors

Indexed keywords

ADRENALIN; C PEPTIDE; GLUCOSE; HYDROCORTISONE; INSULIN; NORADRENALIN;

ADRENALIN BLOOD LEVEL; ADULT; ARTICLE; CIRCADIAN RHYTHM; CLINICAL ARTICLE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYDROCORTISONE BLOOD LEVEL; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; LOW DRUG DOSE; MALE; MEAN ARTERIAL PRESSURE; NORADRENALIN BLOOD LEVEL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ADULT; C-PEPTIDE; FEMALE; GLUCOSE CLAMP TECHNIQUE; HUMANS; HYDROCORTISONE; HYPERGLYCEMIA; INSULIN; INSULIN RESISTANCE; MALE; NOREPINEPHRINE; VASOCONSTRICTOR AGENTS;

EID: 80052559635     PISSN: 15207552     EISSN: 15207560     Source Type: Journal    
DOI: 10.1002/dmrr.1212     Document Type: Article

References (28)

1. Cely CM, Arora P, Quartin AA, Kett DH, Schein RM. Relationship of baseline glucose homeostasis to hyperglycemia during medical critical illness. Chest 2004; 126(3): 879-887.
2. Yang SY, Zhang S, Wang ML. Clinical significance of admission hyperglycemia and factors related to it in patients with acute severe head injury. Surg Neurol 1995; 44(4): 373-377.
3. Gray CS, Taylor R, French JM, et al. The prognostic value of stress hyperglycaemia and previously unrecognized diabetes in acute stroke. Diabet Med 1987; 4(3): 237-240.
4. Capes SE, Hunt D, Malmberg K, Gerstein HC. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet 2000; 355(9206): 773-778.
5. Thourani VH, Weintraub WS, Stein B, et al. Influence of diabetes mellitus on early and late outcome after coronary artery bypass grafting. Ann Thorac Surg 1999; 67(4): 1045-1052.
6. van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in the critically ill patients. N Engl J Med 2001; 345(19): 1359-1367.
7. Malmberg K, Norhammar A, Wedel H, Rydén L. Glycometabolic state at admission: important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction: long-term results from the Diabetes and Insulin-Glucose Infusion in Acute Myocardial Infarction (DIGAMI) study. Circulation 1999; 99(20): 2626-2632.
8. Williams LS, Rotich J, Qi R, et al. Effects of admission hyperglycemia on mortality and costs in acute ischemic stroke. Neurology 2002; 59(1): 67-71.
9. Furnary AP, Gao G, Grunkemeier GL, et al. Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg 2003; 125(5): 1007-1021.
10. Malmberg K, Rydén L, Hamsten A, Herlitz J, Waldenström A, Wedel H. Effects of insulin treatment on cause-specific one-year mortality and morbidity in diabetic patients with acute myocardial infarction. DIGAMI Study Group. Diabetes Insulin-Glucose in Acute Myocardial Infarction. Eur Heart J 1996; 17(9): 1337-1344.
11. Finfer S, Chittock DR, Su SY, et al., The NICE-SUGAR Study Investigators. Intensive versus conventional glucose control in critically ill patients. N Engl J Med 2009; 360(13): 1283-1297.
12. McCowen KC, Malhotra A, Bistrian BR. Stress-induced hyperglycemia. Crit Care Clin 2001; 17(1): 107-124.
13. Hotamisligil GS, Spiegelman BM. Tumor necrosis factor alpha: a key component of the obesity-diabetes link. Diabetes 1994; 43(11): 1271-1278.
14. Mizock BA. Alterations in carbohydrate metabolism during stress: a review of the literature. Am J Med 1995; 98(1): 75-84.
15. Kuroda M, Honnor RC, Cushman SW, Londos C, Simpson IA. Regulation of insulin-stimulated glucose transport in the isolated rat adipocyte. cAMP-independent effects of lipolytic and antilipolytic agents. J Biol Chem 1987; 262(1): 245-253.
16. Schloerb PR, Henning JF. Patterns and problems of adult total parenteral nutrition use in US academic medical centers. Arch Surg 1998; 133(1): 7-12.
17. Frankenfield DC, Reynolds HN, Badellino MM, Wiles CE, 3rd. Glucose dynamics during continuous hemodiafiltration and total parenteral nutrition. Intensive Care Med 1995; 21(12): 1016-1022.
18. Stuart CA, Shangraw RE, Prince MJ, Peters EJ, Wolfe RR. Bed-rest-induced insulin resistance occurs primarily in muscle. Metabolism 1988; 37(8): 802-806.
19. De Backer D, Biston P, Devriendt J, et al., SOAP II Investigators. Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med 2010; 362(9): 779-789.
20. Marangou AG, Alford FP, Ward G, et al. Hormonal effects of norepinephrine on acute glucose disposal in humans: a minimal model analysis. Metabolism 1988; 37(9): 885-891.
21. Ferrannini E, Mari A. How to measure insulin sensitivity. J Hypertens 1998; 16(7): 895-906.
22. Deibert DC, DeFronzo RA. Epinephrine-induced insulin resistance in man. J Clin Invest 1980; 65(3): 717-721.
23. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979; 237(3): E214-E223.
24. Liu D, Moberg E, Kollind M, Lins P-E, Adamson U, Macdonald IA. Arterial, arterialized venous, venous and capillary blood glucose measurements in normal man during hyperinsulinaemic euglycaemia and hypoglycaemia. Diabetologia 1992; 35(3): 287-290.
25. Morris AD, Petrie JR, Ueda S, et al. Pressor and subpressor doses of angiotensin II increase insulin sensitivity in NIDDM. Dissociation of metabolic and blood pressure effects. Diabetes 1994; 43(12): 1445-1449.
26. Sacca L, Morrone G, Ciacala M, Corso G, Ungaro B. Influence of epinephrine, norepinephrine, and isoproterenol on glucose homeostasis in normal man. J Clin Endocrinol Metab 1980; 50(4): 680-684.
27. James DE, Burleigh KM, Kraegen EW. In vivo glucose metabolism in individual tissues of the rat. Interaction between epinephrine and insulin. J Biol Chem 1986; 261(14): 6366-6374.
28. Silverberg AB, Shah SD, Haymond MW, Cryer PE. Norepinephrine: hormone and neurotransmitter in man. Am J Physiol 1978; 234(3): E252-E256.